جستجوی استاد راهنمای دانشگاهی

• Bioethics
• Pharmaceutical Ethics
• Clinical Trial Ethics
• +۴ مورد دیگر

Jennifer E Miller is an Associate Professor of Medicine (General Internal Medicine) and Biomedical Informatics & Data Science at Yale School of Medicine. She serves as Co-Director of the Program for Biomedical Ethics and holds leadership positions including Director of the Good Pharma Scorecard (an index that ranks pharmaceutical companies on bioethical performance) and Founder of Bioethics International. Her academic appointments reflect her interdisciplinary expertise spanning clinical medicine, ethics, and data science. Dr. Miller's research program focuses on critical ethical dimensions of biomedical innovation, with particular emphasis on ethics, equity and governance in drug, vaccine, and medical device research, development, and accessibility. She specializes in developing metrics to enhance accountability and social responsibility in the pharmaceutical industry. Her work examines clinical trial diversity, international research ethics, healthcare data sharing, and the implementation of ethical frameworks in medical product development. Through the Good Pharma Scorecard initiative, she has created a systematic approach to evaluating pharmaceutical company performance across multiple ethical dimensions including clinical trial transparency, diversity in research participation, and access to medicines. Analysis of Dr. Miller's recent publications (2021-2025) reveals a strong thematic focus on diversity and equity in clinical research, with particular attention to demographic representation in trials, ethical considerations in international trial site selection, and equitable access to newly approved drugs and vaccines. Her work bridges bioethics, health policy, and data science, creating measurable frameworks for assessing ethical performance in the pharmaceutical industry. The interdisciplinary nature of her research connects clinical medicine, public health, and corporate accountability, with direct implications for regulatory policy and industry practice. Appointment to World Economic Forum Center for the Fourth Industrial Revolution, Precision Medicine Council (2019) Appointment to World Economic Forum Biotechnology Council (2018) Appointment to World Economic Forum Futures Council (2017) Appointment to World Economic Forum Human Enhancement Working Group (2017) Fellow at Foundation Brocher for Ethical Issues in Global Population Health (2014) As Director of the Good Pharma Scorecard and Founder of Bioethics International, Dr. Miller leads initiatives that connect academic research with practical applications in industry ethics. Her work involves collaboration with pharmaceutical companies, regulatory agencies, and patient advocacy groups to develop and implement ethical standards in biomedical innovation. Through editorial roles at journals including Nature Medicine, The BMJ, and JAMA, she influences discourse on research ethics and scientific integrity. Dr. Miller is actively involved in advising and mentorship through her academic appointments at Yale, where she contributes to training the next generation of researchers in biomedical ethics and data science.

• Computational Biology
• Single-Cell RNA Sequencing
• Virology
• +۴ مورد دیگر

Fabio Zanini is an Associate Professor at the University of New South Wales (UNSW) , leading a research group focused on computational biology , single-cell approaches , and transcriptomic analysis across diseases like severe dengue , neonatal lung disease , cancer , and marine biology . He previously conducted postdoctoral research at Stanford University (2016-2019) and earned a PhD in Bioinformatics from the Max Planck Institute for Developmental Biology and the University of Tuebingen (2015). Current Affiliation: Group leader, UNSW Previous Training: Postdoc (Stanford), PhD (Max Planck/University of Tuebingen) His research spans single-cell RNA sequencing , computational virology , developmental cell biology , and bioinformatics tool development , with recent work on: Severe dengue progression (viral-host interactions, immune signatures) Lung development (endothelial cell diversity, hyperoxia-induced injury) Cancer genomics (mutant HSC clones, AZA therapy response) Marine biology (plankton transcriptomics, evolutionary analysis) Bioinformatics (HTSeq 2.0, northstar algorithm) Recent scientific awards include grants from the Chan Zuckerberg Initiative ($270,000), NIH R01 (multiple), ARC Discovery Grant , and NHMRC Ideas Grant . Notable contributions include: Northstar - Cell classification algorithm SpectralSeq - Hyperspectral-transcriptomic integration Tabula Muris - Mouse aging atlas He has supervised research into hematopoietic stem cell regulation , lung vascular development , and autophagy in viral infections , with collaborations across Stanford , University of Sydney , and Harvard .

Charlotte Kloftمشاهده پروفایل

استاد

• Pharmacometrics
• Computational Disease Modeling
• Therapeutic Drug Monitoring
• +۶ مورد دیگر

Professor Charlotte Kloft is Head of the Department of Clinical Pharmacy & Biochemistry at the Institute of Pharmacy, Free University of Berlin since 2011, and spokesperson for the interdisciplinary Graduate Research Training Program PharMetrX 'Pharmacometrics and Computational Disease Modelling' since 2008. She previously served as Professor and Head of the Department of Clinical Pharmacy at Martin-Luther-University Halle-Wittenberg (2005-2011) and as Scientific Assistant/Senior Assistant at Freie Universität Berlin (1999-2005). Her academic credentials include a habilitation in Clinical Pharmacy from Freie Universität Berlin (2003) and a Dr. rer. nat. (summa cum laude) from the same institution (1997). She earned her license as a pharmacist in 1992 after completing pharmacy studies at Johannes Gutenberg-University, Mainz (1987-1991). Professor Kloft's research focuses on pharmacometrics, computational disease modeling, and therapeutic drug monitoring across multiple therapeutic areas. Her work bridges pharmaceutical sciences with clinical practice, with particular emphasis on personalized dosing strategies for oncology, antimicrobial resistance, and inflammatory bowel diseases. She has pioneered research in optimizing drug dosing through pharmacokinetic/pharmacodynamic modeling, with applications in both antibiotic and cancer therapies. Her recent publications demonstrate a strong evolution toward integrating advanced computational approaches with clinical pharmacology, including machine learning applications in pharmacometrics, personalized dosing strategies for biologics during pregnancy, and developing nationwide infrastructure for therapeutic drug monitoring in cancer therapy through the ON-TARGET study. Academic Center of Excellence of Pharsight (now Certara), USA (since 2000) Habilitationsreisestipendium of Dr. August and Dr. Anni Lesmüller-Stiftung (2002) Ernst-Reuter-Preis of Ernst-Reuter-Gesellschaft (1998) Joachim-Tiburtius-Preis of Berlin Senate (1998) Young Investigator Award of EORTC-PAMM (1997) Professor Kloft has successfully supervised numerous doctoral students whose research spans diverse areas including CAR-T cell therapy, antimicrobial resistance, inflammatory bowel disease treatment optimization, and pharmacokinetic modeling of novel therapeutic agents. Her research group has secured significant funding for projects including GlobalResist, ON-TARGET, ABIMMUNE, COMBINATORIALS, and TAIN. She leads a vibrant research ecosystem at the Free University of Berlin with strong collaborations across Europe and internationally, maintaining state-of-the-art laboratory facilities including Biosafety Level 2 certified labs for infectious disease research.

Kibret Mequanintمشاهده پروفایل

استاد

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۶ مورد دیگر

Dr. Kibret Mequanint is a full Professor at Western University's Department of Chemical and Biochemical Engineering, with cross-appointments in Biomedical Engineering. Holding a PhD from University of Stellenbosch and postdoctoral experience at Technical University of Darmstadt and McMaster University, his research bridges polymer science, materials engineering, and life sciences with applications in Biomaterials , Tissue Engineering , and Regenerative Medicine . His work spans both fundamental and translational research in cell-material interactions , polymer biomaterial design , and therapeutic radiation dosimeters , with technologies transferred to commercial applications. Leading scholar and educator with awards from NSERC, CIHR, and Western University Fellow of: American Institute for Medical and Biological Engineering (AIMBE), Ethiopian Academy of Sciences, International Union of Societies for Biomaterials Science and Engineering, Canadian Academy of Engineering Extensive editorial and panel service for NSERC, CIHR, and international journals His research program has produced over 170 refereed publications, focusing on conductive hydrogels , bioadhesives , and vascular tissue engineering . Recent work on endoscopy-deliverable bioadhesives and snake venom-derived hemostatic gels has attracted global media attention. He has served in leadership roles at the Canadian Biomaterials Society and university governance bodies including Senate and Board of Governors.

Anthony Brownمشاهده پروفایل

دانشیار

• Cancer Biology
• Wnt Signaling
• Stem Cells
• +۷ مورد دیگر

Anthony Brown is an Associate Professor in the Department of Cell and Developmental Biology at Weill Cornell Medical College, part of the Graduate School of Medical Sciences. He has been a faculty member since 1987 and currently serves as Director of the Office of Medical Student Research. Education: B.A. in Natural Sciences (Genetics), University of Cambridge, 1977 M.A., University of Cambridge, 1980 Ph.D. in Molecular Biology, University of Edinburgh, 1982 Postdoctoral Fellow, University of California, San Francisco (with Harold Varmus) Postdoctoral Fellow, University of Strasbourg (with Pierre Chambon) Dr. Brown's research focuses on the Wnt family of signaling proteins and their roles in tissue development, homeostasis, and cancer. His work has significantly advanced the understanding of both canonical and non-canonical Wnt pathways, particularly in breast and colorectal cancers. He has shown that Wnt signaling contributes to oncogenesis through mechanisms involving stem-like cells, epithelial-to-mesenchymal transition, and crosstalk with other signaling cascades such as TGFβ. His research employs diverse models including cell culture, organoids, mouse models, and patient-derived tissues. His recent publications reveal a strong emphasis on Wnt signaling in cancer stem cells, metastasis, and signal transduction mechanisms. Trends include the role of Wnt in tumor microenvironments, regulation of ribosomal DNA, and therapeutic targeting of multiple pathways simultaneously. His work frequently appears in high-impact journals such as PNAS, Cancer Research, and Development. Scientific Awards: Royal Society European Science Exchange Fellowship Medical Research Council (U.K.) Travelling Fellowship Cornell Scholars Award Andrew W. Mellon Teacher-Scientist Award Pew Scholar in the Biomedical Sciences Irma T. Hirschl Career Scientist Award WCM Awards for Teaching Excellence WCM Awards for Excellence in Medical Education Dr. Brown has been actively involved in grant-funded research, including as a Co-Investigator on the Clinical and Translational Science Center (UL1) grant awarded by the National Center for Advancing Translational Sciences (2022–2027). He collaborates with a broad network of co-investigators across disciplines. He also mentors students and contributes to medical education, reflecting his dual commitment to research and teaching. His laboratory investigates Wnt signaling mechanisms and their implications for cancer therapeutics.

Tony Ingessonمشاهده پروفایل

مدرس ارشد

• Intelligence Analysis
• Counter-espionage
• Military Decision-Making
• +۴ مورد دیگر

Tony Ingesson is a Senior Lecturer in the Department of Political Science at Lund University, specializing in intelligence analysis, counter-espionage, and military decision-making. With a background in the Swedish Armed Forces where he worked with technical data acquisition for airborne weapons systems and communications, he brings practical military experience to his academic work. His research interests span intelligence analysis methodologies, counterintelligence operations, deception and manipulation at tactical levels, clandestine communications, and industrial espionage. Ingesson has developed a particular expertise in how psychological mechanisms and biases influence intelligence analysis, as well as the historical connections between military conscription and democratization. His work bridges theoretical political science with practical security applications. Analysis of his recent publications reveals a strong focus on contemporary security challenges, particularly the intersection of traditional and emerging technologies in intelligence operations. His work examines how historical communication methods persist in modern conflicts, the evolving nature of espionage in high-trust societies like Sweden, and the application of intelligence analysis techniques to non-traditional fields such as precision oncology. Ingesson demonstrates consistent scholarly output across both academic journals and public-facing platforms like The Conversation, indicating his commitment to making complex security issues accessible to broader audiences. Ingesson actively participates in interdisciplinary research projects, including 'Clandestine Communications: Old Technologies, New Opportunities' and 'Greyzone genomics' at the Pufendorf IAS. His teaching portfolio encompasses political science methods, intelligence analysis techniques, counterterrorism, and deception studies, reflecting the breadth of his expertise. While specific details about student advising aren't provided in the available information, his role as Senior Lecturer indicates involvement in mentoring students through his teaching responsibilities. His research team involvement includes collaboration with researchers like Magnus Andersson on clandestine communications and David Gisselsson Nord on the intersection of genomics and security. These collaborations demonstrate his ability to bridge disciplinary boundaries while maintaining focus on core intelligence and security issues.

Paul Raysonمشاهده پروفایل

استاد

• Natural Language Processing
• Corpus Linguistics
• Semantic Multilingual NLP
• +۷ مورد دیگر

Professor Paul Rayson is a Professor of Natural Language Processing in the School of Computing & Communications at Lancaster University, UK. He serves as Director of the UCREL (University Centre for Computer Corpus Research on Language) interdisciplinary research centre and is affiliated with multiple research institutes including Security Lancaster, the Lancaster Centre for Digital Humanities, and the Data Science Institute. Education: PhD in Computer Science, Lancaster University (2003) BSc (Hons) Computer Science and Mathematics, Lancaster University (1990) Professor Rayson's research focuses on semantic multilingual Natural Language Processing (NLP) in challenging linguistic environments with noisy language data, including historical texts, learner language, speech, email, and other computer-mediated communication. His work spans applications in dementia detection, mental health analysis, online child protection, cyber security, learner dictionaries, and text mining of biomedical literature, historical corpora, and financial narratives. He has developed semantic tagging tools like USAS (UCREL Semantic Analysis System) and Wmatrix for corpus analysis. Major Awards and Honors: FHEA (Fellow of the Higher Education Academy) MBCS (Member of the British Computer Society) Professor Rayson has supervised numerous PhD students in NLP and corpus linguistics, with eight current students and seven completed doctorates. He has led or co-investigated multiple major research projects including the £3.5m ESRC-funded Centre for Corpus Approaches to Social Science (CASS), the National Corpus of Contemporary Welsh, and projects related to mental health forums, financial narrative analysis, and cyber security. His research has been supported by ESRC, EPSRC, and other funding bodies. As Director of UCREL, he oversees research in corpus linguistics and NLP. He is also active in the Cyber Security Research Centre, Digital Health Group, and multiple Data Science Institute initiatives. His lab has developed several widely-used NLP tools including CLAWS for English POS tagging, USAS semantic analysis system, Wmatrix corpus analysis tool, and the Variant Detector (VARD) for historical texts.

• Bioorganic Chemistry
• Chemical Biology
• Organic Chemistry
• +۵ مورد دیگر

Prof. Dr. Norbert Sewald, Chair of Organic and Bioorganic Chemistry at Bielefeld University, is a leading figure in Bioorganic Chemistry , Chemical Biology , and Enzymatic Halogenation . As head of the Organic and Bioorganic Chemistry Group at the Center for Biotechnology (CeBiTec), he drives research on natural products and drug conjugates. Full Professor, Bielefeld University (since 1999) Founding Coordinator, International Graduate School of Chemistry and Biochemistry (2001-2003) Chairman, Institute of Biochemistry and Bioengineering at CeBiTec (2006-2008) Dean, Department of Chemistry (2008-2011) Chairman, Max-Bergmann-Kreis e.V. (since 2010) Coordinator, Marie Skłodowska-Curie Training Networks (MAGICBULLET, 2015-2018; Magicbullet::reloaded, 2020-2023) His research focuses on halogenases for mild peptide bromination, cryptophycin-based tumor targeting , and bioactive natural products from African flora. Collaborative projects span antiplasmodial agents , antibacterial compounds , and neurodegenerative disease inhibitors . Recent work highlights include: Enzymatic halogenation cascades Click-to-release drug conjugates Fluorescent probes for amyloid detection Key affiliations: Faculty of Chemistry Center for Biotechnology (CeBiTec) European Peptide Society (Scientific Affairs Officer, 2016-) Leibniz Institute of Plant Biochemistry (Scientific Advisory Board, 2010-2017)

• DNA Nanotechnology
• Molecular Robotics
• Self-Assembling Nanostructures
• +۴ مورد دیگر

Dr. Shelley Wickham is an Associate Professor and ARC DECRA Fellow at the University of Sydney, holding joint appointments in the Schools of Chemistry and Physics. She serves as a Westpac Research Fellow and leads the DNA Nanotechnology Group at the Sydney Nano Institute. Dr. Wickham is also co-Champion of the Sydney Nano Institute Grand Challenge project in Molecular Nanorobotics for Health, co-lead of the School of Physics Grand Challenge on Nanoscale brain navigation for targeted drug delivery, and faculty mentor of the University of Sydney BIOMOD team. Bachelor of Science and Master of Science in Physics from University of Sydney PhD in Condensed Matter Physics from University of Oxford Postdoctoral Fellow at Harvard Medical School, Dana-Farber Cancer Institute, and Wyss Institute Dr. Wickham's research focuses on self-assembling nanotechnology and molecular robotics, particularly in the design and assembly of programmable nanostructures out of DNA. Her work spans applications in cell biology, materials science, and nanomedicine. Current research projects include design and synthesis of self-assembling DNA nanostructures, proto-cells made of DNA gels that move under flow, new plasma fabrication methods for biomolecule micropatterning, and DNA computation circuits for navigating the brain using machine learning. Her research aligns with the Faculty of Science Research Strengths in Molecules to Materials, Preventing and Treating Disease & Disorder, and Next Generation Materials. Analysis of Dr. Wickham's recent publications reveals a consistent focus on DNA nanotechnology with increasing sophistication in structural complexity and biological applications. Her work has evolved from fundamental DNA origami structures to increasingly complex multi-component systems with practical applications in nanomedicine and biomimetic engineering. Recent publications show strong interdisciplinary collaboration across chemistry, physics, biology, and engineering disciplines, with emphasis on real-world applications including drug delivery systems and biomolecular sensors. ARC DECRA Fellow Westpac Research Fellow BIOMOD World Champions (2019) Dr. Wickham actively mentors PhD students and postdoctoral researchers in her DNA nanotechnology group. She has secured significant research funding including ARC Discovery Projects, Westpac Scholarships, and NSW Health grants. Her current grants support projects such as '3D Bio-Nanomaterial Displays with Designer Architectures and Functions' and 'RNA aptamer sensing devices for rapid detection of blood clotting.' Dr. Wickham encourages applications from diverse backgrounds and maintains active collaborations with researchers at Harvard, Oxford, and other international institutions. Dr. Wickham leads the DNA Nanotechnology Group at the University of Sydney, which is part of the Sydney Nano Institute. Her lab focuses on building tools from DNA origami - including tweezers, spanners, wrenches and springs - to better understand biological processes at the nanoscale. The group has achieved notable success with the BIOMOD team winning world championships in 2019, and continues to develop innovative approaches to molecular robotics for healthcare applications.

Amir Bahadoriمشاهده پروفایل

استاد

• Radiation Protection
• Radiation Transport
• Radiation Dosimetry
• +۵ مورد دیگر

Amir Bahadori serves as Professor and Nuclear Engineering Program Director in the Department of Mechanical and Nuclear Engineering at Kansas State University's Carl R. Ice College of Engineering, holding the Hal and Mary Siegele Professorship in Engineering. He directs the Radiological Engineering Analysis Laboratory (REAL) and established the Institute for Radiation Health Studies (IRHS) in 2024, focusing on radiation protection, space radiation environments, and radiation health effects. His educational background includes: Ph.D. in Biomedical Engineering, University of Florida (2012) M.S. in Nuclear Engineering Sciences, University of Florida (2010) B.S. in Mechanical Engineering and Mathematics, Kansas State University (2008) Bahadori's research spans radiation transport modeling, dosimetry, and risk assessment with applications in space exploration, medical physics, and radiation epidemiology. He develops computational frameworks for radiation exposure scenarios and biological response prediction, emphasizing space radiation protection for Artemis missions and chronic exposure studies through the Million Person Study collaboration. Analysis of his recent publications reveals dominant themes in space radiation measurement (Artemis missions), radiation epidemiology (Million Person Study innovations), and advanced detection systems (miniaturized neutron spectrometers). His work increasingly integrates big data approaches for radiation risk assessment and electrostatic shielding concepts for deep-space exploration. His scientific recognition includes: NASA Graduate Student Research Fellowship (2009) Certified Health Physicist designation Big 12 faculty fellowship (2022-2023) NCRP council election (2024) Two USPTO patents Bahadori secures substantial research funding from NASA for space radiation instrumentation, Department of Energy projects via the Kansas City National Security Campus, and collaborative epidemiological studies. He mentors nuclear engineering graduate students while leading interdisciplinary teams developing radiation protection solutions for aerospace and medical applications. His laboratory infrastructure includes the REAL with Beocat high-performance computing resources, radiation detectors, and a 3D printer, plus the IRHS with a Precision X-ray XRad320 irradiator and radon chamber. These facilities support collaborations across K-State colleges and external organizations for radiation health effect studies.

Neda Haj Hosseiniمشاهده پروفایل

مدرس ارشد

• Biomedical Engineering
• Medical Imaging
• Artificial Intelligence in Healthcare
• +۳ مورد دیگر

Neda Haj Hosseini is a Senior Lecturer and Associate Professor in Biomedical Engineering at Linköping University's Department of Biomedical Engineering (IMT) . She contributes to teaching courses like TBMT56 - Medical Technology and TBME08 - Biomedical Modeling and Simulation , while leading research initiatives in AI-driven cancer diagnostics and biomedical optics. Research Focus: Development of AI methods for cancer diagnostics, optical coherence tomography (OCT) applications, and fluorescence spectroscopy in surgical guidance Affiliations: Center for Medical Image Science and Visualization (CMIV) , Analytic Imaging Diagnostic Arena (AIDA) , Swedish Medical Technology Association Recent Research Trends demonstrate expertise in applying deep learning to: Pediatric brain tumor classification using multimodal imaging Optical biopsy techniques for intraoperative decision support Automated biomarker quantification in histopathology Medical imaging data integrity and algorithm validation Scientific Awards include grants from: Joanna Cocozza Foundation (2022) Swedish Childhood Cancer Foundation (2024) Academic Leadership involves mentoring students in projects such as: "Multiple Instance Attention-based Learning for Brain Tumor Classification" "Vision Transformers for Multiclass Brain Tumor Tissue Classification" "Reaction-diffusion Models for Image-driven Tumor Simulation"

Leah Schubertمشاهده پروفایل

دانشیار

• Medical Physics Education
• Radiation Oncology Safety
• Quality Assurance
• +۶ مورد دیگر

Leah Schubert, PhD is an Associate Professor in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. She serves as Director of the Medical Physics Residency Program, leading educational initiatives in medical physics training. Her professional focus centers on improving safety, quality, and educational standards in radiation oncology physics. Dr. Schubert earned her PhD from the University of Wisconsin - Madison in 2009 and completed her undergraduate studies with a BS from the University of California–San Diego in 2003. She is board certified in Therapeutic Medical Physics by the American Board of Radiology (2012). Her research spans medical physics education, radiation safety, quality assurance, and functional imaging applications in radiation therapy. She has pioneered work in physics plan review training, safety checklist implementation, and 4DCT-ventilation imaging for functional avoidance radiation therapy. Her educational research focuses on concept inventories, virtual interviewing for residency matches, and cross-institutional residency training frameworks. Analysis of her recent publications reveals a consistent focus on improving safety culture in radiation oncology through systematic approaches including failure modes and effects analysis, simulated error training, and safety checklist development. Her work increasingly incorporates cross-institutional collaboration and educational innovation in medical physics training. ABR Volunteer Services Award, American Board of Radiology (2023) Board Member at Large, Society of Directors of Academic Medical Physics Programs (2022) AAPM Fellow, American Association of Physicists in Medicine (2022) Excellent Patient Safety Role Model, University of Colorado Hospital (2021) ABR Volunteer Services Award, American Board of Radiology (2020) IAEA Competition Towards a Strong Safety Culture in Radiation Medicine, International Atomic Energy Agency (2019) As Director of the Medical Physics Residency Program, Dr. Schubert oversees comprehensive training for future medical physicists, implementing innovative approaches to curriculum development and assessment. Her leadership extends to national committees including the AAPM Work Group on Periodic Review of Medical Physics Residency Training and various SDAMPP committees. She has secured funding for educational initiatives focused on improving residency training standards and safety culture development. Dr. Schubert collaborates extensively with multi-institutional research teams, particularly in the area of 4DCT-ventilation imaging and its clinical applications for functional avoidance radiation therapy. Her work bridges clinical practice, safety initiatives, and educational innovation in medical physics.

Natalie Johnsonمشاهده پروفایل

دانشیار

• Environmental Toxicology
• Air Pollution Health Effects
• Developmental Biology
• +۴ مورد دیگر

Natalie Johnson is an Associate Professor in Environmental and Occupational Health at the College of Veterinary Medicine, Texas A&M University. She chairs the Interdisciplinary Program in Toxicology and leads critical research on air pollution impacts on vulnerable populations. Education PhD in Toxicology, Texas A&M University College of Veterinary Medicine Postdoctoral Fellowship in Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health BS in Biology, Texas A&M University College of Science Her research focuses on inhalation toxicology , maternal exposure to pollutants , and gene-environment interactions . She directs the mobile responding to air pollution in disasters (mRAPiD van), a real-time chemical pollutant detection platform, and investigates emerging environmental chemicals in breast milk. Current projects include: Respiratory toxicology of inhaled pollutants Prenatal/pediatric air pollution exposure and immune development Development of green-engineered clays for toxin mitigation

Benedikt Warthمشاهده پروفایل

استاد

• Exposomics
• Metabolomics
• Analytical Chemistry
• +۴ مورد دیگر

Benedikt Warth is a Full Professor for Food Chemistry and Exposome Research at the Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna (since 2022). He coordinates the Austrian node of the ESFRI research infrastructure EIRENE and leads the 'Global Exposomics and Biomonitoring Laboratory' since 2017. His work bridges chemistry and toxicology, focusing on exposomics and metabolomics to assess chemical exposure and its health impacts. Education: PhD in Analytical Chemistry (2012), Master’s in Biotechnology (2009), Bachelor’s in Food Science and Biotechnology (2007) Research interests center on exposomics , metabolomics , and analytical chemistry , particularly for environmental and food-related toxicants. Recent articles highlight advancements in mass spectrometry for exposome-scale analysis, combining targeted and non-targeted approaches, and exploring chemical interactions (e.g., xenoestrogens, mycotoxins, flame retardants) in biological systems. Key trends in his publications include: Development of hybrid LC-MS methods (targeted/untargeted) for sensitive exposomics Integration of AI and cognitive computing for pathway analysis Global biomonitoring of mycotoxins and xenobiotics in vulnerable populations Standardization frameworks for non-targeted analysis (SRT) Notable awards include the 2025 Chemical Research in Toxicology Young Investigator Award , Brigitte Gedek-Science Award , and multiple grants (ERC Consolidator, Erwin-Schrödinger Fellowship). He has delivered over 20 invited talks on exposomics, including sessions at ACS Fall Meetings and international conferences. His laboratory's projects span: Breast cancer exposomics (linking environmental exposures to disease onset) High-throughput sample preparation for exposome-wide studies Systems toxicology of chemical mixtures (e.g., flame retardants, mycotoxins) Development of global metabolomic assays for toxicity prediction

• Radiation Biophysics
• Cancer Radiotherapy
• Ionizing Radiation Effects
• +۴ مورد دیگر

David J. Brenner serves as Higgins Professor of Radiation Biophysics in Radiation Oncology and Environmental Health Sciences at Columbia University Medical Center. He directs both the century-old Center for Radiological Research and the Radiological Research Accelerator Facility (RARAF), leading interdisciplinary teams focused on radiation applications in medicine and safety. BA in Physics from Oxford University (1974) MSc in Radiation Physics from University of London (1976) MA in Physics Philosophy from Oxford University (1979) PhD in Physics from University of Surrey (1980) His research spans dual aspects of radiation: therapeutic applications in cancer treatment and risk assessment across diverse scenarios. Key initiatives include advancing carbon-ion therapy for pancreatic cancer, developing safe far-UVC light for pathogen elimination, and investigating low-dose radiation risks from medical imaging to nuclear terrorism. His team leverages RARAF's unique capabilities for mechanistic studies of radiation effects. Publications reveal dominant themes in radiation biophysics, with significant contributions to biodosimetry (RABiT platform), UV disinfection technology, and cancer risk modeling. Recent work emphasizes translational applications including medical countermeasures for radiation exposure and precision radiation oncology techniques. National Academy of Sciences Nuclear and Radiation Studies Board member National Council on Radiation Protection and Measurements member Radiation Research Society Failla Gold Medal recipient (2011) Oxford University Weldon Prize for mathematical biology (2015) Robert D. Moseley Award for Radiation Protection in Medicine Brenner leads multiple NIH-funded projects including biodosimetry development and UV disinfection research. His mentorship extends through directing Columbia's Radiological Research Accelerator Facility and training programs in radiological sciences. Current lab efforts focus on carbon-ion therapy mechanisms and 222-nm UV applications against drug-resistant pathogens, with active collaborations across oncology, microbiology, and physics disciplines.